Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2038 of 5804
-
Ancient herbal recipe put to the test for PCOS
Disease control CompletedPolycystic ovary syndrome is the most common endocrine and metabolic disorder in gynecology. Traditional Chinese medicine has a good clinical effect in the treatment of PCOS. We intend to conduct this trial in strict accordance with the requirements of evidence-based medicine, th…
Phase: PHASE1, PHASE2 • Sponsor: Jiangxi University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New radioactive drug combo takes aim at returning head and neck cancers
Disease control CompletedThis is a Phase 1 study of the use of an investigational drug that selectively delivers radiation to malignant tumor cells, CLR 131, in combination with external beam radiation therapy (EBRT) in subjects with locoregionally recurrent head and neck cancer. The trial will enroll up…
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
Can this watch spot a hidden heart problem?
Diagnosis OngoingWithings Move ECG watch is designed to record ECG and detect automatically atrial fibrillation. The aim of this study is to validate the performance of Move ECG watch to detect atrial fibrillation compared to a reference 12-lead ECG.
Sponsor: Withings • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Which works best for high potassium? new study tests three emergency options
Disease control CompletedHyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease, diabetes mellitus, or heart failure. Globally, the reported incidence of hyperkalemia varies from 1.1 to 10 per 100 hospitalizations, depending on the patient cohort and comorbid…
Phase: PHASE4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Gold nanoparticles tested as brain energy boost for MS
Disease control CompletedREPAIR-MS is a single-center open label, sequential group, investigator and patient blinded study to assess the CNS metabolic effects, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in patients who have been diagnosed with Multiple Sclerosis (MS) within fifteen (15) ye…
Phase: PHASE2 • Sponsor: Clene Nanomedicine • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Cancer drug safety checked in Long-Term study
Disease control CompletedThis is an open-label, multicenter, extension study to evaluate the long-term safety and efficacy of BeiGene or BeOne investigational drugs in participants with advanced malignancies who participated in a prior BeiGene- or BeOne-sponsored clinical study (parent study).
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Nasal cell test may predict cystic fibrosis drug success
Knowledge-focused CompletedThe purpose of the study is to investigate whether the correction of CFTR function by Lumacaftor/Ivacaftor in a patient-derived primary nasal cell model is a surrogate biomarker for respiratory improvement in Orkambi® treated patients.
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New device may help colorectal cancer patients avoid a temporary colostomy
Disease control CompletedA clinical trial to assess the efficacy, mechanism of action and safety of the Colovac+ Colorectal Anastomosis Protection Device in providing temporary protection of the anastomosis in subjects undergoing lower anterior resection for colorectal cancer
Phase: NA • Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New MRI scan could replace liver biopsies for iron overload patients
Diagnosis CompletedThe overall goal of this research is to help develop a new magnetic resonance (MR) method, Quantitative Susceptibility Mapping (QSM), to improve the measurement of liver iron concentrations without the need for a liver biopsy. Measurement of liver iron is important to diagnose an…
Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Could a simple blood test catch lung hypertension early?
Diagnosis CompletedThe primary purpose of this study is to identify and develop biomarker signatures based on circulating micro ribonucleic acid (RNA) in the blood samples associated with high risk of pulmonary hypertension (PH) to assist in the diagnosis of PH; to estimate the sensitivity, specifi…
Phase: EARLY_PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Diagnosis
Last updated Jun 26, 2026 16:39 UTC
-
Balloon battle: which coated catheter wins for tiny heart arteries?
Disease control CompletedA Randomized Trial Comparing the Agent Paclitaxel-Coated PTCA Balloon Catheter vs SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Real-World data shows lanadelumab cuts HAE attacks over three years
Disease control CompletedThe main aim of this study is to compare the number of HAE attacks occuring in persons using lanadelumab with the number of HAE attacks before lanadelumab treatment was started. Data from participants who start the study after 1 March 2021, will be collected for 24 months; data …
Sponsor: Shire • Aim: Disease control
Last updated Jun 26, 2026 13:06 UTC
-
New cocktail aims to outsmart pancreatic cancer
Disease control OngoingThis phase I trial studies the side effects and best dose of anetumab ravtansine when given together with nivolumab, ipilimumab and gemcitabine hydrochloride in treating patients with mesothelin positive pancreatic cancer that has spread to other places in the body (advanced). An…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Custom-Made vaccine takes on ovarian cancer
Disease control CompletedThis is a multicenter, open-label, single arm phase I study evaluating the safety and tolerability as well as some activity parameters of TG4050 in patients with ovarian, fallopian or peritoneal serous carcinoma.
Phase: PHASE1 • Sponsor: Transgene • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
MRI-Guided radiation: a sharper weapon against cancer?
Knowledge-focused OngoingThis study is being done to help further understand how MR-guided adaptive RT in conjunction with the Integrated Magnetic Resonance Linear Accelerator (MRL) can improve patient outcomes. This study will include participants who will be receiving radiotherapy using the MRL machine…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Vitamin compound studied for rare brain disease PKAN
Disease control CompletedThe purpose of this study is to learn more about how people with the condition pantothenate kinase-associated neurodegeneration (PKAN) respond to a specialized study product. We are hoping to find out if the study product is safe, what effects-good and bad-the study product cause…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New ointment shows promise for rare skin scaling disease
Symptom relief CompletedThe purpose of this study is to investigate the efficacy and safety of two concentrations of topically applied ointment formulation of isotretinoin called TMB-001 (0.05% and 0.1% isotretinoin) in subjects 9 years of age and older for the treatment of congenital ichthyosis (CI), i…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can online therapy help first responders cope? new study seeks answers
Symptom relief Recruiting nowThis study evaluates a transdiagnostic Internet-delivered cognitive behavioural therapy (ICBT) recently tailored for Canadian public safety personnel (PSP) reporting symptoms of depression, anxiety, or posttraumatic stress. Outcomes of interest include engagement with the interve…
Phase: NA • Sponsor: University of Regina • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New Heart-Shaped surgery may improve bowel function in kids with Hirschsprung's
Disease control CompletedComparison of Circular(Soave)and Heart-shaped Anastomosis in Hirschsprung's disease.
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Breakthrough fertility method may keep estrogen low during cancer treatment
Disease control CompletedThe present investigation aims to evaluate the efficacy of an innovative protocol of controlled ovarian stimulation for breast cancer patients, who are candidates for fertility preservation. Currently, vitrification of oocytes and/or embryos after controlled ovarian stimulation …
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC